bullish
Ipca Laboratories - On Course to Revive Earnings Growth
The domestic formulation (DF) segment continues on its robust growth path, led by market share gain, favorable price hikes, addition of medical representatives
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 22-minute read)
Discussions
(Paid Plans Only)
Motilal Oswal
External broker reports(aggregated public sources)
Motilal Oswal Financial Services Limited
- Ipca Laboratories - On Course to Revive Earnings Growth24 Jun 2022
x